ERBISOL Extra, solution for injections, ampules 2ml #10

ERBISOL Extra, solution for injections, ampules 2ml #10

$52.00

A characteristic feature of ERBISOL® products is the original mechanism of action, according to which they act not so much on the disease as on the whole organism, activating the controlling systems of the body responsible for the search for and elimination of pathological changes. One of the main such monitoring systems is the immune system. The drugs specifically activate the immune system, the effectiveness of which manifests itself primarily through the action of the macrophage link, which contributes to the repair of damaged cells and the restoration of the functional activity of organs and tissues, and also through the N- and T-killers responsible for the destruction of abnormal cells and tissues. ERBISOL® products in their composition contain low-molecular “signal” fragments of membrane glycoproteins performing the function of “markers of the physiological state of cells”, which, in pathological disturbances of homeostasis, activate the natural evolutionarily formed control systems of the body responsible for the search for and elimination of pathological changes in organs and tissues.

  • Description
  • Additional information
  • Doses and Uses
  • Shipping & Payment
  • Reviews (0)

Description

Erbisol Extra.
A characteristic feature of ERBISOL products is the original mechanism of action, according to which they act not so much on the disease as on the whole organism, activating the controlling systems of the body responsible for the search for and elimination of pathological changes. One of the main such monitoring systems is the immune system.

The drugs specifically activate the immune system, the effectiveness of which manifests itself primarily through the action of the macrophage link, which contributes to the repair of damaged cells and the restoration of the functional activity of organs and tissues, and also through the N- and T-killers responsible for the destruction of abnormal cells and tissues.

ERBISOL products in their composition contain low-molecular “signal” fragments of membrane glycoproteins performing the function of “markers of the physiological state of cells”, which, in pathological disturbances of homeostasis, activate the natural evolutionarily formed control systems of the body responsible for the search for and elimination of pathological changes in organs and tissues.

One such system is the immune system.

ACTIVE INGREDIENTS: 1 ml of the preparation contains: a complex of natural non-protein low-molecular organic compounds of non-hormonal origin, derived from animal embryonic tissue, oligopeptides and glycopeptides (generally 0.07-0.4 mg), nucleotides, amino acids.
Excipients: 0.9% sodium chloride isotonic solution.

SPECIFICITY of IMMUNOMODULATING PROPERTIES of ERBISOL® PRODUCTS:

  • activate macrophage cells involved in the repair of damaged cells and regeneration of organs and tissues with the restoration of their functional activity;
  • activate the killer series cells (N- and T-killers and cytotoxic T-lymphocytes CD8 ), responsible for the destruction of damaged cells that are unable to regenerate, or abnormal cells (mutant, malignant, virus carriers, etc.) and tissues;
  • are immunocorrectors: they normalize the activity of Th1 and Th2 lymphocytes and restore the balance of cytokines, thereby harmonizing the state of cellular and humoral immunity, as well as inhibiting the course of autoimmune and allergic processes.

ACCELERATE the DESTRUCTION of ABNORMAL and the RESTORATION of DAMAGED CELLS and TISSUES. ERBISOL® products ONLY affect unbalanced systems, affected organs and tissues and remain practically indifferent to a healthy organism without causing side effects, i.e. drugs are harmless, do not lead to drug poisoning in case of overdoses or long-term use. Excellent means for disease prevention.
Increase the protective and adaptive functions of the body.
Will help to realize your physiological potential for a full-fledged way of life.

ERBISOL Extra, as an immunomodulator, activates, in the main, macrophages.
In this regard, it is intended to strengthen the repair of damaged cells and regenerate organs and tissues during restoration of their functional activity, which is especially effective in the treatment of diseases of the nervous, endocrine and cardiovascular systems.

The exclusive rights to ERBISOL products are protected in 20 countries of the world on the basis of international applications PCT / UA93 / 00003 and PCT / UA93 / 00004, including:
European Patent No. 0673652, No. 0673653, US Patents No. 08/397287, No. 08/397288, No. 2041715, No. 2041715 of Ukraine, No. 2164 of Ukraine, No. 2163, of Belarus No. 2039, No. 2040, of Poland No. 173321, No. 173302, of Bulgaria No. 61679 , No. 61680, ….

PHARMACOLOGICAL PROPERTIES ERBISOL EXTRA:
Pharmacodynamics. The pharmacological activity of the preparation is determined by the content of low-molecular biologically active peptides in it, which are characterized by immunomodulating, reparative, antioxidant and antihypoxic effects.

The main immunomodulating effect of the drug is manifested primarily through the effect on the macrophage link responsible for the repair of damaged cells and the restoration of the functional activity of organs and tissues, as well as through NK cells (CD316 56 ) and T-killers (CD3 16 56 ), responsible for the destruction of damaged cells that are unable to regenerate, or abnormal cells. Simultaneously, the drug has an immunocorrective effect and in the case of immune status disorders it contributes to its normalization, activating T-lymphocytes, Th1-helpers and T-killers, which is important for restoring the balance between cellular and humoral immunity.

The drug is non-toxic, devoid of cumulative toxicity, allergenic, teratogenic, mutagenic and carcinogenic properties.

INDICATIONS ERBISOL EXTRA:
in complex therapy:

  • Cardiovascular diseases: AH, cardiomyopathy, myocarditis, IHD, myocardial infarction, postinfarction cardiosclerosis, diffuse cardiosclerosis;
  • neurological diseases: cerebral atherosclerosis, stroke, neurological disorders associated with impaired cerebral circulation (after a stroke), polyneuritis of various genesis, demyelizing polyneuropathy, Parkinson’s disease;
  • Gastrointestinal diseases: acute and chronic hepatitis of various etiology, hepatopathies, hepatoses, liver cirrhosis, pancreatitis, erosive gastroduodenitis, gastric ulcer and duodenal ulcer, ulcerative colitis;
  • nonspecific diseases: nonspecific lung diseases (pneumonia, chronic bronchitis), metabolic dystrophies, angiopathy, to improve microcirculation, normalization of vascular tone and vascular blood filling, chronic rheumatism, diffuse connective tissue diseases, systemic vasculitis, arthritis of various etiologies, deforming osteoarthrosis, gout. Erbisol Extra is used in the complex treatment of people affected by the effects of radiation exposure and environmental pollution, the drug has a pronounced adaptive-corrective properties, increases the compensatory and protective functions of the body;
  • diabetes mellitus, thyroiditis, autoimmune insulin syndrome;
  • periodontitis and periodontosis;
  • in surgery and traumatology: obliterating diseases of the aorta and its branches of atherosclerotic genesis, obliterating endarteritis, diabetic macro- and microangiopathies, traumatic, postoperative and purulent wounds, trophic ulcers of different etiology, pressure ulcers, fractures (to accelerate the consolidation of bone fragments);
  • in allergology: allergic diseases, including asthma, atopic dermatitis and atopic rhinoconjunctivitis;
  • skin diseases: pustular skin diseases, dermatitis and toxicodermia, neurodermatoses, eczema, psoriasis;
  • in gerontology: functional insufficiency, associated with age-related disorders of the liver, immune, nervous and cardiovascular system. To increase physical activity and general vitality, potency.

CONTRAINDICATIONS: Individual intolerance, hypersensitivity to any component of the drug.
STORAGE CONDITIONS: At a temperature of 4-12 ° C. During storage, opalescence may occur.


external

Additional information

Weight 150 g
Forms of release

Solutions for injections

Volume / Weight

2 ml #10

Packing

Ampoules

Manufacturer

ERBIS

Country/Region of Manufacture

Ukraine

APPLICATION:

  • the drug Erbisol Extra is used exclusively as part of complex therapy and injected daily in/m 2-4 ml for 20-30 days 2 times a day, preferably in the morning, at 06:00-08:00, 1-2 hours before meals (in the treatment of pancreatic diseases – at 09:00-11:00 2-3 hours after meals), and in the evening, before going to bed, at 20:00-22:00, 2-3 hours after meals.
  • In the complex therapy of neurological diseases (demyelizing polyneuropathies, Parkinson’s disease), Erbisol Extra is prescribed intravenously twice a day: at 06:00-08:00 and 20:00-22:00, 2 ml for the first 3 days, the following 10-20 days are administered twice: at 06: 00-08: 00 for 4 ml and at 20:00-22:00 for 2 ml, and then for 7-17 days – 2 times in 2 ml.
  • In complex treatment for neurological disorders associated with impaired cerebral circulation (after a stroke), in the post-infarction period, Erbisol Extra is recommended to be prescribed 7-10 days after an epicrisis in/m daily 2 ml in the morning for 20-30 days.
  • In the complex therapy of IHD, and violations of peripheral circulation, the drug is prescribed intravenously twice a day for 2 ml for 20 days.
  • In a complex treatment for obliterating diseases of the vessels, the drug is administered in/m droplet in 4 ml, diluted in 250 ml of physiological solution for 1-2 hours. The maintenance dose is provided in/m injections of the drug every 2 times 2 ml in the morning and in the evening. The course of treatment is 10-15 days.
  • In the complex therapy for ulcerative colitis, Erbisol Extra is given intravenously 2 ml 2 ml each morning and night for 20-30 days, then every day 4 ml in the morning and 2 ml in the evening for 20-30 days, and then every day for 2 ml in the morning and in the evening for 10-20 days.
  • With the complex therapy of wounds, periodontitis and periodontosis, the first 10 days are prescribed in/m daily 2 times a day for 2 ml in the morning and in the evening, and the next 10 days, if necessary, 2 ml in the morning. In generalized paradontitis, additional applications and electrophoresis of Erbisol Extra are prescribed from the anode ( ) on the gums.
  • Complex treatment of hepatoses, hepatitis, erosive and ulcerative lesions of the gastrointestinal tract, diffuse connective tissue diseases, traumatic tissue and organ damage, trophic ulcers of various etiologies, decubitus, to accelerate the consolidation of bone fragments, and to enhance the compensatory and protective functions of the body, increase physical activity and of the general vitality of Erbisol Extra are prescribed daily 2 ml of 2 ml in the morning and evening for 20 days, or for the first 3 days to 2 ml in the morning, and the next 10 days, two rows 2 ml morning and evening, then – 7 days to 2 ml in the morning.
  • With the complex therapy of pancreatitis for the first 10-20 days, Erbisol Extra is administered twice daily: 2 ml in the morning, at 09:00-11:00, and in the evening, at 20:00-22:00, and then the following 10-20 days – 2 ml every morning.
  • As part of complex therapy for diabetes during the first 20 days, Erbisol Extra is prescribed twice daily: 2 ml every morning at 09:00-11:00 and in the evening at 20:00-22:00, followed by the next 10 days – 2 ml in the morning. The course of treatment can be repeated 2-3 times a year.

Children. The safety and efficacy of the drug have not been investigated in children, so it is not recommended for children to prescribe it.
INTERACTIONS: Erbisol Extra increases the effect of antibacterial agents, exogenous interferons and at the same time reduces their toxic effect. To effectively implement the directed immunomodulatory effect, Erbisol Extra is not recommended to be administered with immunomodulators that stimulate humoral immunity. Erbisol Extra increases the sensitivity of receptors, so when using hormonal drugs and biostimulants simultaneously with it, you should monitor their dose, reducing it if necessary.
INCOMPATIBILITY. To effectively implement the directed immunomodulatory action, Erbisol Extra should not be used concomitantly with:
a) alcohol (neutralizes the reparative effect of macrophages);
b) immunomodulators that can stimulate humoral immunity, which hinders the action of T-killers.
OVERDOSE: A short-term increased excitability that does not require specific therapy is possible.

STANDART SHIPPING WORLDWIDE
WEIGHT (kg) COST ($US) ESTIMATED

DELIVERY TIME

TRACKING
0 - 0.199 6.50 15 - 21 working days Available
0.200 - 0.250 8.00 15 - 21 working days Available
0.251 - 0.500 14.00 15 - 21 working days Available
0.501 - 1.000 20.00 15 - 21 working days Available
1.000 - 2.000 25.00 15 - 21 working days Available

PAYMENT

  • We accept Visa, MasterCard via AdvCash & Payeer (there are problems with the possibility).
  • We accept SEPA, BACS.
  • We accept RIA.
  • We accept Cryptocurrency.
  • PayPal.

Depending on the method of payment, additional Fees / VAT are charged.

And also there is a system of bonuses that you can spend on your next purchases.

Reviews

There are no reviews yet.


Only logged in customers who have purchased this product may leave a review.

You've just added this product to the cart: